Uncertainties in interspecies extrapolations of carcinogenicity. by Crouch, E A
Environmental Health Perspectives
Vot 50, pp. 321-327, 1983
Uncertainties in Interspecies
Extrapolations of Carcinogenicity
by E. A. C. Crouch*
The usual classification of results of animal carcinogenicity tests is positive or negative. Attempt-
ing to observe correlations between species using such results is complicated by differing test sensi-
tivities. In these circumstances it is helpful to use models to represent the experimental data in a
consistent way. Fitting the model parameters to the data allows computation of confidence limits
and an assessment of concordance or discordance between different species in a way which accounts
for differing test sensitivities. This paper describes this approach in detail for one class of models
applied to the carcinogenicity test results of 187 of the NCI bioassay series, allowing comparison be-
tween B6C3F1 mice, Fischer 344 rats and Osborne Mendel rats. It is shown that the uncertainties in
extrapolating between species are larger than generally acknowledged (a standard deviation of a
factor of "4.5), but that within these uncertainties there are few if any discordances.
Introduction
When a test for carcinogenicity is performed on
groups of experimental animals, the usual way of re-
porting the result is qualitative -as a positive when
a dosed group of animals has a sufficiently large ex-
cess tumor rate or a negative if any excess tumor
rates are not sufficiently large. The criterion for suf-
ficiency is usually statistical, while the negativity of
any result is usually qualified by the experimental
conditions, among which are the dose of material
under test and the numbers of animals tested. At-
tempts have been made to observe correlations be-
tween species by using such qualitative results (1),
the first step in verifying efforts at extrapolation
between species, but they are complicated by the
differing experimental conditions and hence differ-
ing sensitivities. Furthermore, the measures of cor-
relation which may be obtained from qualitative re-
sults are limited, and the application of these mea-
sures to interspecies extrapolation is unhelpful,
since such extrapolations are usually required to be
quantitative.
Under these circumstances, the use of models is
helpful in condensing the considerable experimental
data into a few convenient, quantitative parameters
which may then be used as surrogates for all the ex-
perimental data. The definitions of the model and
its parameters may be chosen to incorporate such
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biases as the existence of a background rate for tu-
mors, the expectation that tumor incidence rates
rise as dose of carcinogen is increased, and the ex-
pectation that tumor incidence is stochastic. If the
model is then applied to a large set of experiments
on different materials in various species, the values
of the model parameters obtained in each case rep-
resent uniform measures of the experimental re-
sults in each case, and are thus ideal candidates for
observing correlations and for use in extrapolation.
Moreover, it is usually possible to obtain some sort
of measure of uncertainty and significance for such
parameters, allowing a better assessment of concor-
dance or discordance between experimental results.
The purpose of this paper is to give some details
of this approach by using a particular model and to
show the results obtained when this model is ap-
plied to the data generated by the National Cancer
Institute (NCI) Carcinogenesis Bioassay program.
Method
The NCI Carcinogenesis Bioassays constitute a
large number of experiments performed with simi-
lar protocols, and thus are ideal for this approach.
The model chosen (2) to fit the data generated is de-
fined as follows.
The measure of dose chosen is defined to be the
lifetime integrated mass of material ingested mea-
sured in bodyweights. (See Appendix A for the
methods used for computing doses). For conve-E. A. C. CROUCH
nience this dose is expressed as an average dose
rate by dividing by nominal lifetimes.
Tumor occurrence is a stochastic process occur-
ring with a probability p related to the dose d de-
fined above by
p = 1 - (1 - a)exp{ - 3d/(1 - a)} a 0
p
where a and P are the parameters of this model, a
representing the background tumor incidence while
P is a measure of the carcinogenic strength of the
material under test. P is referred to as the potency
of the material.
In any group ofNanimals fed the test material at
a (group average) dose d, tumor incidence r is a ran-
dom variable with a binomial probability distribu-
tion given by
PHr =() pr (1 p)N - r (2)
where P(r) is the probability of observing r animals
with tumors, and p is given by the expression (1)
above.
By using this definition of the model, an estimate
of the potency P and approximate confidence limits
associated with the uncertainties due to numbers of
animals tested may be found using maximum likeli-
hood methods (Appendix B). In addition, the signifi-
cance of this estimated potency can be calculated
exactly under the assumptions of the model (Appen-
dix C).
This analysis has been repeated for almost every
set of results reported in the summary tables set
out in the NCI Carcinogenesis Bioassay Reports.
Data from pooled or historic control groups were
used in preference to data from the matched control
groups, and time adjusted data were used preferen-
tially whenever presented. Testicular tumors in
male Fischer 344 rats were entirely omitted from
the analysis.
In addition, similar calculations have been per-
formed with a modified measure of dose, chosen so
as to weight the doses given at each age with a
weight factor corresponding to that expected in a
linearised Doll-Armitage model (3) in which the car-
cinogen affects just one stage (Appendix D). The es-
sential results obtained do not differ (for the param-
eters so far tested) from those found with the un-
weighted measure of dose described above, and are
not presented separately.
In order to compare between species it is neces-
sary to select amongst all the potency estimates
obtained. The available selection criteria, together
with the choices used in this paper, are: (A) chemi-
cal: whole database of 187 chemicals; (Bi) species:
B6C3F1 mouse, Osborne Mendel rat, Fischer 344
rat; (B2) sex: male, female, either; (B3) tumor type/
site: any; (C) significance of potency estimate: vari-
ous (see Table 1), no correction made for multiple
comparisons; (D) size of potency estimate: largest.
(Bi), (B2) and (B3) were logically ANDed to-
gether. These criteria were applied in the order
given to obtain a single value for each chemical
tested. Confidence bounds were taken to be the
lower confidence limit associated with the potency
estimate selected and the highest upper confidence
limit on all potency estimates satisfying (A) - (B3).
Thus the upper confidence bound represents a mea-
sure of the sensitivity of the experiment. In most
cases this upper confidence bound came from the
same data that generated the selected potency esti-
mate. By generating estimates of potency in this
way with differing choices (of species, sex, tumor
type/site) it is possible to compare them between
these choices.
The purpose of this paper is to compare between
species, so repeating the selections with differing
species and all other selection criteria similar gives
the required data. Each chemical may then be rep-
resented on a graph by a point with coordinates cor-
responding to the potency estimates obtained in the
different species. Of course, for many chemicals
there were no results significant in one or both spe-
cies. Those with no significant result in either spe-
able 1.
Logarithm of potency ratio
p= 0.01 p= 0.025 p= 0.05
Species Mean + S.D. n Mean + S.D. n Mean + S.D. n
(F344 or OM)/B6C3F1 0.283 + 0.716 36 0.207 + 0.681 51 0.170 ± 0.662 66
F344/B6C3F1 0.456 ± 0.669 26 0.362 ± 0.648 37 0.337 ± 0.609 48
OM/B6C3F1 -0.169 ± 0.662 10 -0.201 ± 0.610 14 -0.276 ± 0.603 18
Males
F344/B6C3F1 0.632± 0.760 12 0.370± 0.746 20 0.436± 0.714 29
OM/B6C3F1 -0.050± 0.670 7 -0.122± 0.692 8 -0.300± 0.769 12
Females
F344/B6C3F1 0.369 ± 0.631 16 0.376 + 0.579 20 0.280 ± 0.569 28
OM/B6C3F1 0.004± 0.645 8 0.012± 0.631 12 -0.098± 0.646 14
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cies can be discarded as providing no useful infor-
mation, but those with just one significant result
are potential exceptions to any relationship found
between potency estimates in the two species com-
pared. In these cases one can plot the significant re-
sult in one species versus the upper confidence
bound found for all results in the other species, and
check whether this disagrees with any apparent in-
terspecies relations. The confidence limits shown in
this paper are approximate 95% limits (90% confi-
dence intervals).
There are sufficient data to present comparisons
between B6C3F1 mice and Fischer 344 (F344) rats,
and between B6C3F1 mice and Osborne Mendel
(OM) rats. The comparisons extend over nonoverlap-
ping sets of chemicals, since each chemical was
tested in only one strain of rat.
Results
Since the usual method of extrapolating between
species (as used in regulatory efforts aimed at esti-
mating effects on humans) is to take the largest sig-
nificant effect seen in one species (independent of
sex), we present results first with no sex discrimina-
tion. Figures 1, 2 and 3 are plots of the logarithm (to
base 10) of potency in B6C3F1 mice versus the same
in F344 rats. The criteria used (B and C above) are
shown as labels on the graphs. A total of 78 chemi-
cals showed a significant (pO0.025, uncorrected for
multiple comparisons) result in one or both of these
species. The 37 significant in both are plotted in Fig-
ure 1, with the confidence limits, and again in Fig-
ure 2 without, while 22 significant in just one spe-
cies are shown in Figure 3. The remaining 17 signifi-
cant in just one species are not plotted, since they
are obviously in agreement with the results of Fig-
ure 1 (i.e., on these plots, the arrows indicating the
possible range of values point towards the dashed
lines). The dashed line is a least-squares unit slope
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mice versus the same in F344 rats.
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regression on to the 37 points of Figure 1, a line cor-
responding to proportionality between species re-
sponses. Some statistics of these and later plots are
shown in Table 1.
Figure 1 is included to illustrate that confidence
intervals calculated solely on the basis of sample
sizes and binomial distributions do not explain the
variance between results in different species, most
of which must thus arise elsewhere. The distribu-
tion of points is clearer in Figure 2, where the confi-
dence intervals have been removed. Clearly, any at-
tempt to extrapolate between these two species
must take into account the uncertainty indicated by
this graph. The standard deviation about the re-
gression line (Table 1) is 0.66, corresponding to a fac-
tor of 4.5. We have elsewhere suggested (4) how this
may be taken into account.
On Figure 3 are plotted those cases which do not
naively agree with the regression line. As can be
seen, most appear consistent with a distribution
leading to Figures 1 and 2, with only one (piperonyl
sulfoxide, causing hepatocellular carcinoma in male
mice) deviating substantially. Figures 4 and 5 show
similar results for B6C3F1 mice versus OM rats.
Once again, one can note that confidence intervals
based on numbers of animals tested fail to cover the
range of deviations between species, but that within
these larger deviations there appear to be no ob-
vious exceptional cases-or rather that the experi-
ments as designed have not shown up any such
cases.
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FIGURE 4. Logarithms of carcinogenic potency in B6C3F1
mice versus the same in OM rats.
This process can be repeated for various selec-
tions. The general features of the resulting plots are
similar to those displayed, and a few of the statis-
tics generated are shown in Table 1. The numerical
values shown in Table 1 correspond to the logarith-
mic plots displayed, and so refer to the logarithm (to
base 10) of the ratios of potencies estimated in the
species/strains in the left hand column. The values
obtained are fairly stable against changes in the sig-
nificance selection criterion, as may be seen by com-
paring the values given forp K 0.01,p < 0.025 andp
K 0.05. All values agree within their estimated stan-
dard errors.
Discussion
The results illustrated here indicate that using
this model, extrapolation of carcinogenic potency
between rats and mice is uncertain, the standard
deviation of the logarithm (to base 10) of the ratio of
potencies measured in mice and rats amounting to
about 0.65 (a factor of 4.5). Strictly speaking, the un-
certainties found in Table 1 apply only to the dose-
response model as defined earlier in this paper, and
then only for high doses. However, it seems unlikely
that any other dose-response model is likely to do
much better in this high dose regime, except possi-
bly if it is highly nonlinear in the range of doses
tested. This possibility is, of course, open to test in
the way outlined in this paper.
As mentioned earlier, changing the measure of
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Table 2. Based on Table 1 p = 0.025 data.
Logarithm of potency ratios
Species Body weight basis Surface area basisa
(F344 or OM)/B6C3F1 0.21 ± 0.10 -0.17 ± 0.10
F344/B6C3F1 0.36± 0.11 0.03± 0.11
OM/B6C3F1 -0.20 ± 0.16 -0.61 ± 0.16
Males
F344/B6C3F1 0.37 ± 0.17 0.02 ± 0.17
OM/B6C3F1 -0.12± 0.24 -0.54± 0.24
Females
F344/B6C3F1 0.38± 0.13 0.06± 0.13
OM/B6C3F1 0.01 ± 0.18 -0.37 ± 0.18
a Computed by assuming surface area is proportional to the two-thirds power of body weight, with the following typical body
weights used: B6C3F1 (m) 32g, B6C3F1 (f) 28; OM (m) 600g, OM (f) 400g; F344 (m) 350g, F344 (f) 250g.
dose by weighting dose rates with their time of ad-
ministration has little effect on this measure of un-
certainty. This result is not surprising, since many
of the chemicals contributing to the large variance
were fed to the animals at constant dose rates in
these experiments, so that this form of weighting
has little effect on the ratios of doses fed to the dif-
ferent animals, no matter how those doses are mea-
sured. Similarly, using a dose measure based on sur-
face area (e.g., mg/m2-day) will not affect his mea-
sure of uncertainty, since such a dose measure is re-
lated to the one used (mg/kg-day) by a surface area
to weight ratio which has much lower variance
within a species. The only effect of changing to such
a dose measure is to change the mean value of the
interspecies potency ratio, represented by the po-
sition of the intercept of the dashed lines on the
graphs shown.
The data of Table 1 are equivocal in their support
for extrapolations between species solely on the
basis of dose measured per unit surface area (practi-
cally, two-thirds power of body weight). Suppose
that (, and P2 are potencies measured in species 1
and 2 on the basis of doses d, and d2 measured
in mass per unit body weight, and that similar,
primed, variables representing similar quantities
are defined for doses measured in mass per unit
surface area.
Then (/P = dld' W-13, where W is body
weight, and so 1'/12" = (11/12) (W, 1W2)-113. Using typ-
ical weights for the animals in these experiments
gives the results shown in Table 2. As can be seen,
extrapolation on a bodyweight basis appears best
for the OM to B6C3F1 comparison, on a surface
area basis for the F344 to B6C3F1 comparison, and
neither is particularly good if all the data are com-
bined for a single rat to mouse comparison. Al-
though it has been shown (5) that an acute toxicity
measure may be extrapolated between species by
using measure of dose based on surface area (with
an uncertainty substantially less than those ob-
served in this paper), the rat appeared to be excep-
tional in giving biassed estimates using this proce-
dure. We are left wondering if the rat is exceptional
for carcinogenicity extrapolation also.
Appendix A:
Dose Calculations
Dose Adninistered on Weight Basis For those
experiments in which the material was adminis-
tered by gavage, doses were specified and adminis-
tered on a weight basis (mg/kg), usually by adjust-
ing dose sizes according to average weights of
groups of animals. Total lifetime dose was obtained
by summing over all individual doses, and normal-
ised to a dose rate (mg/kg-day) by dividing by nomi-
nal lifetimes, assumed to be 91 weeks for mice and
104 weeks for rats.
Dose Administered as a Fraction of Diet Here
doses were specified as a fraction (ppm or %) of the
diet. To compute a lifetime integrated dose in body
weights required the use of feeding curves for the
experimental animals. Data on feeding of OM rats
and B6C3F1 mice were provided in Carcinogenesis
Bioassay Report No. TR2. From these data it was
found that the cumulative intake of food measured
in body weights (obtained by dividing weekly or
four weekly food intake by the mean of the weights
of the animals at the beginning and end of each
week or four weeks, and summing from the begin-
ning of the experiment) are well fitted by a curve of
the form:
F(t) = b(1 - exp{ - at}) + dt + Ct2
where F(t) is the cumulative intake in body weights
at age t and a, b, c, d are parameters estimated
from the data.
The parameters were estimated from data on
groups of animals on control diets. To allow for
weight differences between different groups of ani-
mals, and between OM and F344 rats, it was as-
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sumed that food intake is proportional to the two-
thirds power of body weight, so that food intake
measured in body weights is proportional to the in-
verse one-third power of body weight. Thus the
cumulative material intake due to a concentration C
of material in the diet a fraction K of the time from
ages t1 to t2 could be expressed as:
KCM-1"3[F(t2) - F(t1)]
for an animal of full grown weight M. Scaling the
parameters a, b, c, d allowed this expression to di-
rectly give the average dose rate (mg/kg-day), using
nominal lifetimes of 91 weeks for mice, 104 weeks
for rats. Full grown weight was estimated by eye
from the growth curves of each experiment, and
corresponded to weight at 60-70 weeks of age. The
fraction K was used when dosing was only carried
out for some fraction of the week. Adding up ex-
pressions like this over the concentration-age
schedule for the experiment gave the total average
dose rate.
The values of the parameters used (with age mea-
sured in weeks, concentration in ppm, and weight in
grams) are given in Table A-1.
Table A-1
a b c d
Male rats 0.132933 8.77459E-2 0.0 3.00191E-3
Female rats 0.184978 0.112783 0.0 3.45399E-3
Male mice 5.90133E-2 8.89311E-2 1.60808E-5 1.84592E-3
Female mice 7.92837E-2 1.19209E-1 8.32436E-6 2.58261E-3
DoseAdministeredin Water. A simple approach
was taken, scaling water intake with full grown
body weight and normalizing to standard animals.
Fitting the scaling law to standard mouse, rat, dog
and man gave water intake as:
T = 0.3629 W-0-2125
where T is daily water intake in body weights and
W is body weight in grams. This relation was as-
sumed to hold for all ages, so that simply multiply-
ing the time integrated concentration of material in
water (in ppm-days) and dividing by nominal life-
times (in days) gave average dose rates in mg/kg-
day.
Appendix B:
Estimation of Potency and
Confidence Limits on Potency
Suppose an experiment is performed in k groups
of animals, with results: number of animals in group
i:Ni; average dose of group i: di; and number of ani-
mals with tumors in group i : ri. The expected prob-
ability of tumors in this group is given by:
Pi= 1 - (1 - a)exp{ - Pdi/(1 - a)}
where the parameters a and P are unknown. The
likelihood function for the k experiments is then
L(a,) II r(Nk ) piri(1 - pi)Ni-ri
Maximizing this with respect to a and P subject to
SA A a > 0 and P > 0 gives estimates a and p of the pa-
rameters.
Approximate (1 - e) confidence limits are ob-
tained by finding the two solutions Pe of:
2{ln[L(6,f)] - ln[L(ae,(le)] = x(1 - 2e)
where x(1 - 2e) is the cumulative (1 - 2e) point of
the chi-squared distribution with one degree of free-
dom and ae is the value of a which maximizes
L(a,fe).
Appendix C:
Significance of Potency Estimate
The significance of the potency estimate is the
probability of observing a potency estimate as high
or higher than the one actually observed, under the
null hypothesis that the true value of potency is
zero, or equivalently that all groups of experimental
animals are samples from the same population. For
any experimental design represented by:
groups ofni animals
i= 1,2,...k
dosed at levelsdiJ
we can obtain a potency estimate P which is a func-
tion of the number of animals with tumors in each
group, saysi; i 1 2, k, so
, = p s ** * Sk)
The observed result is then (3 = /Rr,, r2, .... rk)
where ri is the observed number of tumorous ani-
mals in group 1. Under the null hypothesis, all
groups are equivalent, so the
k
R = r
tumorous animals, are equally likely to be anywhere
among the
k
N= X ni
i= 1
animals.
Hence the probability of observing an estimated
potency as large as actually seen is just the proba-
bility of getting the tumorous animals distributed
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into the k groups in such a way that the potency es-
timate is as large or larger than , that is:
k
ir () t= 1 xSi p=
N
RJ
where the sum is over all values of s,, s2, ..., Sk
which satisfy
k
E si= R
i= 1
and
P(SI,S2,2, .. * Sk) > M = rr2, .. ., rk)
Appendix D:
Dose Weighting for a Linearized
Doll-Armitage Model
In this model it is assumed that a tumor arises af-
ter a sequence of M events have occurred in order.
Assume the probability per unit time of the jth
event ispJt) at age 5. Then ifPn(t) is the probabil-
ity that n events have occurred by age 4 we have:
dxldt = (1 - exp{- Xn-1})Pn n>1
wherexn = - ln (1 - Pn)
dxJldt = p
This may be linearized by assuming all the x to
be small, in which case
dxn/dt = xn Pn n>1
Then we get
Xm(t) =
t rtm t2
|dtmpm(tm) |dtm_ lpm l(tm 1)
... dt,pl(tl)
If all the p(t) are constants except for pjt), (jUm), this becomes
xm(t) =
Cm (t
IT Pi I dx (t -x)m-ixz- 1 pj(x) _j j (m- U( )
Ifpjdepends linearly on dose rate d(t), then this can
be written in the form
et
xm(t) = A + B dx(t - x)m- jxj- 1d(x)
Setting t to be the length of a lifetime and ex-
pressingPm in terms ofxm allows writingPm in the
form of the model adopted in this paper, with a dose
defined by
L
D = ( ILom) |dx (L - x)m-ixi- ld(x)
J)o
where d(t) is the dose rate at age 4 L is the actual
lifetime andLo is a nominal lifetime.
This form of weighting factor was used to deter-
mine a dose variable, where the dose rate was mea-
sured in bodyweights per day and computed as in
Appendix A. The integration was performed by
summing values computed daily.
This work was performed under DOE contract number DE-
AC02-81EV10598. I should like to thank P. Fraenkel for writ-
ing initial versions of several of the computer programs used.
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